-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 8, the State Food and Drug Administration approved Tengsheng Huachuang Pharmaceutical Technology (Beijing) Co.
It is reported that the State Food and Drug Administration, in accordance with the relevant provisions of the "Drug Administration Law" and in accordance with the special drug approval procedures, conducted emergency review and approval, and approved the combination of the above two drugs for the treatment of mild and common types with progression to severe (including hospitalization or Death) adults and adolescents (12-17 years old, body weight ≥40kg) patients with novel coronavirus infection (COVID-19) with high risk factors